Atea Pharmaceuticals (AVIR) EPS (Basic): 2019-2024
Historic EPS (Basic) for Atea Pharmaceuticals (AVIR) over the last 6 years, with Dec 2024 value amounting to -$2.
- Atea Pharmaceuticals' EPS (Basic) fell 129.08% to -$0.41 in Q4 2022 from the same period last year, while for Dec 2022 it was -$1.40, marking a year-over-year decrease of 195.89%. This contributed to the annual value of -$2 for FY2024, which is 22.70% down from last year.
- Atea Pharmaceuticals' EPS (Basic) amounted to -$2 in FY2024, which was down 22.70% from -$1.63 recorded in FY2023.
- Atea Pharmaceuticals' 5-year EPS (Basic) high stood at $1.46 for FY2021, and its period low was -$2 during FY2024.
- Over the past 3 years, Atea Pharmaceuticals' median EPS (Basic) value was -$1.63 (recorded in 2023), while the average stood at -$1.67.
- In the last 5 years, Atea Pharmaceuticals' EPS (Basic) soared by 386.27% in 2021 and then slumped by 195.21% in 2022.
- Over the past 5 years, Atea Pharmaceuticals' EPS (Basic) (Yearly) stood at -$0.51 in 2020, then soared by 386.27% to $1.46 in 2021, then slumped by 195.21% to -$1.39 in 2022, then decreased by 17.27% to -$1.63 in 2023, then fell by 22.70% to -$2 in 2024.